Clinical Trial

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women

Study acronym: RESOLVE-SEX
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Important differences exist between sexes in incidence, disease patterns and outcomes in coronary artery disease that is not well understood. It is likely that key differences in the underlying biological mechanism, in particular in inflammatory responses, play a part in underpinning these differences. Previous evidence demonstrates that healthy females appear to be more adept at resolving inflammation compared to healthy males. Since inflammation is thought to be a key initiating phenomenon in coronary artery disease the investigators will examine the differences in inflammatory resolution between the sexes in healthy volunteers.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-17
Trial Details
NCT Number NCT05597098
Lead Sponsor Queen Mary University of London
Conditions Inflammation
Enrollment 34 participants
Start Date 2022-12-12
Primary Completion 2027-12-12 (estimated)
Study Completion 2027-12-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-16